Asian Spectator

.
Business Advice

.

Octa’s compelling Ramadan 2023—Memories which become templates for the future

KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 27 March 2024 - It is time to recall all the Ramadan initiatives the international broker Octa has launched and curated throughout the last year. C...

Xinhua Silk Road: China international services trade fair clos...

BEIJING, Sept. 10, 2020 /PRNewswire-AsiaNet/ -- China International Fair for Trade in Services (CIFTIS), the first major international economic and trade event held both online and offline b...

LONGi Solar brings its innovative Hi-MO X module to Japan

OSAKA, Japan, Sept. 26, 2019/PRNewswire-AsiaNet/-- - Worth the WaitLONGi launched its new generation Hi-MO X shingled module to Japan. More than 100 industry professionals, customers, partne...

Zhonghua Gas Holdings Limited Announces Audited Results for the Six Months Ended 30 June 2019

- Profit Attributable to Owners Increased 81.5% to HK$37.0 MillionHONG KONG, Aug 13, 2019 - (ACN Newswire) - Zhonghua Gas Holdings Limited (the "Company"; Stock Code: 8246) together with it...

'Discover Ningxia' International Cultural Tourism Festival ends on Perfect Note

NINGXIA, China, Oct 23, 2019 - 'Discover Ningxia' International Cultural Tourism Festival 2019 ended on a perfect note in Ningxia. 20 international 'influencers' and lucky fans of Ningxia, c...

China Dynamics to Provide Not Less Than 500 Electric Vehicles in Philippines and Malaysia

HONG KONG, Mar 25, 2021 - (ACN Newswire) - China Dynamics (Holdings) Limited (the "Company"; Stock Code: 476, together with its subsidiaries, collectively "China Dynamics" or the "Group"), ...

Volcano Berhad Launches Prospectus for IPO

KUALA LUMPUR, Mar 17, 2021 - (ACN Newswire) - Volcano Berhad ("Volcano" or the "Group"), a leading international manufacturer of nameplates and plastic injection moulded parts, has successf...

Chairman of Unilumin Declares 11 Million Share Donation to Uni...

SHENZHEN, China, Dec. 10, 2021 /PRNewswire-Asianet/ -- Global-leading Shenzhen-based LED enterprise Unilumin Group, issued a public announcement. Unilumin's Chairman Lin Mingfeng signed an a...

Huawei Unveils the Green Intelligent OptiX Network, Unleashing...

BARCELONA, Spain, March 3, 2022 /PRNewswire-AsiaNet/ -- At the Mobile World Congress 2022 (MWC 2022), Richard Jin, Vice President of Huawei and President of the Optical Business Product Line...

Agilex Biolabs Taps Biopharma Leader Dr Caroline Popper for Board Chair as part of APAC Bioanalytical Services Growth

Agilex Biolabs Taps Biopharma Leader Dr Caroline Popper for Board Chair as part of APAC Bioanalytical Services Growth

Adelaide, AUS, Apr 2, 2020 - (ACN Newswire) - Award-winning Australian bioanalytical laboratory Agilex Biolabs announced today it has appointed US-based Dr Caroline Popper, MBBS, MPH as Board Chair as part of its APAC clinical trials bioanalytics growth plans.

Agilex Biolabs Taps Biopharma Leader Dr Caroline Popper for Board Chair as part of APAC Bioanalytical Services Growth

Dr Caroline Popper

More than 38% of Agilex Biolabs' biotech clients already come from the APAC region - primarily from China and South Korea. APAC clients are particularly attracted by Agilex' FDA-inspected status, and the more than 40% rebate on clinical trial spend that applies in Australia.

Agilex Biolabs specializes in bioanalysis of small molecules and biologics for PK, immunogenicity, biomarkers and immunological pharmacodynamics assessments, and the only FDA-inspected lab of its type in the region, is located in Adelaide, South Australia in a science and biotech specialist hub.

Dr Popper was first appointed to the Agilex Biolabs Board in July 2019.

Agilex Biolabs CEO Jason Valentine said:

"We are extremely pleased Dr Popper accepted the Board Chair role and we look forward to an exciting phase of growth under her guidance."

"Dr Caroline Popper is a medical doctor, pathologist, health economist, medical consultant and experienced company director, with over 20 years of hands on experience in the healthcare, medical devices and drug discovery fields.

She has managed a wide range of diagnostics, device and drug discovery businesses in both Fortune 500 and start-up settings, at amongst others, Becton Dickinson, bioMerieux, and MDS."

Dr Popper said:

"My clinical experience enables me to help interpret relevant market forces, develop strategies and create partnerships that thrive in the global and fast changing and challenging health care landscape."

"Agilex Biolabs is a stand-out leader in the pharma services space and I look forward to taking on this significant role and being part of the next phase of growth for the company, leveraging its position in the important APAC region."

"The Aglilex Biolabs team of scientists and specialist PhDs is quite exceptional making it well positioned to rapidly deliver bioanalytics for biopharma clients running clinical trials in Australia, Asia and the US, and the EU."

The company specialises in bioanalysis of small molecules and biologics for PK, immunogenicity, biomarkers and immunological pharmacodynamics assessments utilising LC-MS/MS, immunoassay (Mesoscale, Gurolab, Luminex) and flow cytometry (BD FACSymphony A3, 20 colour cell analyser).

Agilex also offers pharmacodynamics services that include immunobiology services using the latest state-of-the-art technology to support immunology, cell biology and mode of action assays, including: - Immunophenotyping- Receptor occupancy- Cytokine release assays (whole blood or PBMC stimulation assays) and cytokine/biomarker profiling- PBMC assays and cellular mechanism of action assays (eg: ADCC)

CEO Jason Valentine said:

"Our FDA-inspected facilities have more than 65 dedicated laboratory staff, and annually support more than 80 clinical trials. This year we will analyse more than 60,000 samples for pharma/biotechs from US, Europe and APAC."

"By combining specialised expertise, technological innovation and a 20-year track record, we have supported hundreds of preclinical and clinical trials around the world."

"Our world-class bioanalytical facilities have OECD GLP Recognition with NATA (Australian Government OECD GLP Compliance monitoring authority) and ISO 17025 Accreditation for global recognition."

Learn more about Agilex Biolabs in this Video: https://youtu.be/3lyodiqqM_k

About Agilex Biolabs

Agilex Biolabs began as a group of academic scientists providing clinical trial and bioanalytical services to the local Australian pharmaceutical industry in the 1980's, and has now grown into a global business for early phase clinical trials. In our 20 years of performing regulated bioanalysis of small and large molecules, we have accelerated hundreds of preclinical and clinical trials around the world. Today, our clients include many of the leading pharmaceutical and biotechnology companies in Asia, Europe and the USA. Call +61 8 83028777 or +1 800 247 1909 or visit https://www.agilexbiolabs.com/.

Agilex Biolabs is built upon four core values that drive our performance:- Scientific excellence and technological innovation- Customer focus- Data integrity and quality assurance- Timeliness/speed

See us featured in Endpoints https://tinyurl.com/uqmkzcu

Media Contact:Team@DMGPR.ComDavid JamesAU: +61 2 8218 2144 USA: +1 415 951 3228Asia: +65 3159 3427

Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

Disparitas pemidanaan: mengapa pelaku kekerasan seksual bisa mendapat hukuman berbeda-beda untuk kasus serupa?

Ilustrasi korban kekerasan seksual.Tinnakorn jorruang/ShutterstockPraktik hukum di Indonesia masih menunjukkan adanya disparitas pemidanaan, yakni ketika ada dua orang atau lebih melakukan tindak pida...

8 aspek penting untuk memastikan keberlanjutan industri nikel dari hulu ke hilir

Isu mengenai hilirisasi nikel Indonesia tengah panas beberapa tahun ke belakang. Ambisi Presiden Joko Widodo untuk menjadikan Indonesia sentra produksi baterai kendaraan listrik (EV) dunia membuat akt...

Gangguan dismorfik tubuh: apa yang perlu kita ketahui tentang kondisi kesehatan mental ini

Selebritas Megan Fox dalam sebuah wawancara dengan Sports Illustrated mengungkapkan bahwa dia memiliki dismorfik tubuh (body dysmorphia). Fox mengatakan: “Saya tidak pernah melihat diri saya sep...



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion